The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 167.50
Bid: 165.00
Ask: 170.00
Change: 12.50 (8.06%)
Spread: 5.00 (3.03%)
Open: 155.00
High: 167.50
Low: 155.00
Prev. Close: 155.00
HUW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorship Change

29 Jun 2023 15:46

RNS Number : 4370E
Helios Underwriting Plc
29 June 2023
 

29 June 2023

Helios Underwriting plc

("Helios" or the "Company")

 

Directorship Change

Helios, the investment vehicle which builds shareholder value through exposure to Lloyd's, is pleased to announce Michael Wade's appointment as Chairman on closure of the Annual General Meeting today. He succeeds Michael Cunningham who has retired from the Company.

Michael Wade has had an extensive career at Lloyd's working across broking, underwriting, capital markets and insurance linked securities. Michael formed one of the first Lloyd's corporate capital vehicles in 1993, CLM Insurance Fund plc, and later acted for UK pension funds via Rostrum Group investing in listed Lloyd's firms. He has served on the Council and Committee of Lloyd's and was formerly a senior adviser to the Cabinet Office. Currently, Michael is also Non-Executive Chairman of Howden Tiger Capital Markets UK and a senior advisor to Mitsui Sumitomo Insurance.

Michael Wade, Chairman of Helios, commented: "I am delighted to be joining Helios as Chairman at this exciting juncture of the Company's journey and I look forward to working closely with the team. Helios should continue to benefit from London's strong trading environment with firm insurance rates and opportunities for the Company to grow."

Martin Reith, Chief Executive Officer of Helios, commented: "I am thrilled to welcome Michael to the Board and look forward to working with him in his role as Chairman. Helios is well positioned to benefit from the current market environment and Michael's extensive industry knowledge and experience will be a huge asset to the Board. I would also like to thank Michael Cunningham for his leadership and dedication to Helios over the past 16 years and wish him well in the future."

AIM Rule 17

Regulatory disclosures in accordance with Rule 17 Schedule Two paragraph (g) of the AIM Rules for Companies.

Michael John Wade, aged 69, holds or has held in the last 5 years the following directorships and/or partnerships:

 

Current directorships / partnerships

Former directorships / partnerships in the past 5 years

 

Tigerrisk Capital Markets & Advisory (UK) Limited

Flood Secure Limited

Lloyd's Index Ltd

London Market Tracker Ltd

Lloyd's Market Tracker Ltd

87 Vincent Square Limited

 

Trexit Limited

Neon Underwriting Limited

TAAGR LLP

 

 

 

 

Michael currently holds 116,470 ordinary shares in Helios.

 

 

In addition, Michael Wade was a director of EUC Re Limited (EUC) at the time it was put into a creditors' voluntary liquidation on 11 March 2005. EUC was subsequently dissolved on 10 September 2014.

 

Save as disclosed above, there are no further disclosures to be made in accordance with Rule 17 or Schedule 2(g) of the AIM Rules for Companies.

For further information, please contact:

Helios Underwriting plc

Martin Reith - Chief Executive Officer +44 (0)7720 292 505

Nigel Hanbury - Executive Deputy Chairman +44 (0)7787 530 404 

Arthur Manners - Chief Financial Officer +44 (0)7754 965 917

 

Numis (Nomad and Broker)

Giles Rolls / Charles Farquhar +44 (0)20 7260 1000

 

Buchanan (PR)

Helen Tarbet / George Beale +44 (0)20 7466 5111

 

About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market writing approximately £297m of capacity for the 2023 account. The portfolio provides a good spread of business being concentrated in property & casualty insurance and reinsurance. For further information please visit www.huwplc.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEALKNALADEFA
Date   Source Headline
22nd Apr 20247:00 amRNSDirectorate Change
25th Mar 20242:53 pmRNSChange of Registered Office
22nd Mar 20247:00 amRNSNAV Update - 31 December 2023
4th Mar 20247:00 amRNSHelios appoints Adhiraj Maitra as COO
1st Feb 20247:00 amRNSTotal Voting Rights
26th Jan 20247:00 amRNSTransaction in Own Shares
25th Jan 20247:00 amRNSTransaction in Own Shares
24th Jan 20247:00 amRNSTransaction in Own Shares
23rd Jan 20247:00 amRNSTransaction in Own Shares
22nd Jan 20247:00 amRNSTransaction in Own Shares
12th Jan 20247:00 amRNSTransaction in Own Shares
11th Jan 20247:00 amRNSTransaction in Own Shares
10th Jan 20247:00 amRNSTransaction in Own Shares
8th Jan 20247:00 amRNSTransaction in Own Shares
4th Jan 20247:00 amRNSTransaction in Own Shares
3rd Jan 20247:00 amRNSTransaction in Own Shares
2nd Jan 20247:00 amRNSTotal Voting Rights
29th Dec 20237:00 amRNSTransaction in Own Shares
28th Dec 20237:00 amRNSTransaction in Own Shares
27th Dec 20237:00 amRNSTransaction in Own Shares
22nd Dec 20237:00 amRNSTransaction in Own Shares
21st Dec 20237:00 amRNSTransaction in Own Shares
20th Dec 20237:00 amRNSTransaction in Own Shares
18th Dec 20234:31 pmRNSShare Repurchase Programme
15th Dec 20237:30 amRNSHelios grows 2024 portfolio to over £500m capacity
11th Dec 202310:03 amRNSTransaction in Own Shares
11th Dec 20239:59 amRNSTransaction in Own Shares
11th Dec 20237:00 amRNSNet Asset Value as at 30 September 2023
7th Dec 20237:00 amRNSTransaction in Own Shares
6th Dec 20237:00 amRNSTransaction in Own Shares
5th Dec 20237:00 amRNSTransaction in Own Shares
4th Dec 20237:00 amRNSTransaction in Own Shares
1st Dec 20237:01 amRNSTransaction in Own Shares
1st Dec 20237:00 amRNSTotal Voting Rights
30th Nov 20237:44 amRNSTransaction in Own Shares
29th Nov 20237:00 amRNSTransaction in Own Shares
28th Nov 20237:00 amRNSTransaction in Own Shares
27th Nov 20237:00 amRNSTransaction in Own Shares
24th Nov 20237:00 amRNSTransaction in Own Shares
22nd Nov 20237:00 amRNSTransaction in Own Shares
8th Nov 20237:00 amRNSCapacity Value Update
7th Nov 202312:43 pmRNSNotification of Major Holdings
7th Nov 202312:38 pmRNSTransaction in Own Shares
7th Nov 20237:00 amRNSTransaction in Own Shares
6th Nov 20237:00 amRNSTransaction in Own Shares
1st Nov 20237:00 amRNSTotal Voting Rights
27th Oct 20237:00 amRNSTransaction in Own Shares
12th Oct 20237:00 amRNSTransaction in Own Shares
10th Oct 20237:00 amRNSDividend Policy & Share Repurchase Programme
4th Oct 202310:50 amRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.